MPH Health Care

AGM Information • Jun 30, 2016

News Details

Corporate | 30 June 2016 16:45

MPH Mittelstaendische Pharma Holding AG: MPH shareholders confirm stable dividend policy

DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): AGM/EGM/Dividend

2016-06-30 / 16:45

The issuer is solely responsible for the content of this announcement.

---

MPH Mittelstaendische Pharma Holding AG:

Annual General Meeting approves dividend of 12 Cent per share;

actions of members of Management Board and Supervisory Board approved with 99% vote

MPH Mittelstaendische Pharma Holding AG, Berlin (ISIN: DE000A0L1H32), reports that the shareholders approved on yesterdays’ AGM with significant majority the proposed dividend of 12 Cent per share, like in the prior year, and therewith decided for continuity. The shareholders approved the actions of the members of the Management Board and of the Supervisory Board for fiscal 2015 by a majority of 99% and approved all of the resolutions.

The Management Board reported a successful development in the first quarter 2016 and a net profit of EUR 8.69 million. The Management Board is looking confident towards a continuing positive profit development in year 2016 based on further product and service offers as well as the opening of additional healthcare service locations in the course of the year 2016.

About MPH Mittelstaendische Pharma Holding AG:

MPH AG is an investment entity strategically focused on the purchase, development and sale of companies and shares in companies especially from the growth segments of the healthcare market. This includes insurance reimbursed segments as well as privately financed segments. But also beyond the healthcare market MPH makes use of potentials of high growth areas.

Key figures for the share of MPH Mittelstaendische Pharma Holding AG:

Subscribed capital: EUR 42,813,842

Listed shares: ordinary shares

ISIN: DE000A0L1H32

WKN: A0L1H3

Stock symbol: 93M

Contact:

Juliane Warning

MPH Mittelstaendische Pharma Holding AG

Grünauer Straße 5

D-12557 Berlin

Phone: +49 (0) 30 897308660 Fax: +49 (0) 30 897308669

E-Mail: ir@mph-ag.de Web: www.mph-ag.de

---

2016-06-30 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	MPH Mittelständische Pharma Holding AG
	Grünauer Straße 5
	12557 Berlin
	Germany
Phone:	030 / 897 308 660
Fax:	030 / 897 308 669
E-mail:	info@mph-ag.de
Internet:	www.mph-ag.de
ISIN:	DE000A0L1H32
WKN:	A0L1H3
Listed:	Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt

End of News	DGAP News Service